Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Real-world experience with idarucizumab for dabigatran reversal in a third-level hospital

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: DOMINGUEZ BRAHONA, Ana (Hospital Virgen de la Salud, Pharmacy)
  • Co-author(s): Ana Dominguez Barahona
    Cristina Blázquez Romero
    Helena Quirós Ambel
    Ana García Sacristán
    Silvia Gonzalez Suarez
    Ana Rosa Rubio Salvador
    Nuria Labrador Andújar
    Paloma Moya Gomez
  • Abstract:

    Background

    Idarucizumab has been approved for use when reversal of the anticoagulant effects of dabigatran is needed for urgent procedures or in patients with life-threatening bleeding.

    Methods

    Observational, descriptive, retrospective (April 2017-April 2018) and longitudinal study of patients treated with idarucizumab in a general hospital of 650

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses